The Evidence

MCS: We Followed the Evidence. Here's Where It Leads.

Bottom line

The evidence does not support the old choice between “toxic load” and “it is psychological.” In consensus-defined MCS, the weight of evidence supports an environmentally initiated and environmentally triggered physiological disorder in susceptible people. Conditioning, expectation, stress, and learned responses can modify an established illness; they do not explain the MCS pattern as a whole, and changing thought has not been shown to reliably restore chemical tolerance.

For decades, people with Multiple Chemical Sensitivity have been forced into a false choice: either they are carrying a vague “toxic load,” or their symptoms are being generated by psychology. The evidence does not place those explanations on equal footing. In consensus-defined MCS, the weight of evidence supports a real physiological disorder initiated and triggered by environmental exposure in susceptible people.

It usually doesn't begin with a theory.

It begins with a person who was living an ordinary life and suddenly—or sometimes gradually—finds that ordinary environments no longer feel ordinary.

Perfume makes them sick. Fresh paint leaves them confused or exhausted. Diesel exhaust brings on symptoms that can involve the head, lungs, heart, stomach, muscles, or nervous system. A building they once could have entered without thinking becomes impossible to tolerate.

Then something stranger happens. The problem may spread. One chemical becomes several. Products that were once harmless become triggers. A person begins planning where to shop, where to sleep, what car to ride in, which hotel room might be survivable, and whether the person walking toward them is wearing fragrance.

For many people, the hardest part is not simply the symptoms. It is being told that the symptoms are not what they seem to be.

EXPOSURE VIGILANCE: WHEN CAUTION COMES AFTER THE BODY HAS ALREADY LEARNED THE HARD WAY

People with MCS often become unusually attentive to environments, odors, products, buildings, traffic, and other possible sources. Critics can look at that vigilance and treat it as evidence that fear caused the reactions. The chronology can be the reverse. If a person is repeatedly made ill by exposures that are invisible, unpredictable, or only identified afterward, vigilance is what repeated physical experience teaches them to do.

Exposure vigilance is not proof that every suspected exposure is correctly identified, and it can become psychologically exhausting. But repeated physical reactions can create caution; caution did not therefore create the reactions. That distinction runs through everything that follows.

The historical argument matters because both stories still shape what patients are told. But this is not a debate in which each side deserves an equal chair. The biological/environmental model has the stronger evidentiary foundation; psychological processes belong mainly in the later questions of modulation, consequence, and coping.

One older model describes repeated toxic overload: chemicals accumulate, detoxification fails, and ever-smaller exposures cause continuing toxic injury. Parts of that story overreach the evidence, especially when every low-level reaction is treated as new poisoning.

The psychological model overreaches more fundamentally when it turns expectation, conditioning, fear, or belief into the cause of consensus-defined MCS. Those processes can modify an established response; the controlled evidence does not show that they generally create the illness or that changing thought reliably restores chemical tolerance.

The way forward is not to split the difference. It is to keep the physiological verdict and then ask which additional mechanisms—sensory, autonomic, immune, metabolic, predictive, or conditioned—help explain how the illness behaves after it begins.

So we started with a different question:

What happens if we stop defending a camp and follow the evidence wherever it goes?

What we found changed the way we understand MCS.

First, what are we actually calling MCS?

Read the page: Is MCS a real physical illness?

This matters because not every headache around perfume is MCS, and not every person who describes themselves as chemically sensitive necessarily has the same condition.

The established 1999 consensus criteria describe MCS as a chronic condition in which symptoms recur reproducibly, occur in response to low levels of exposure, occur with multiple unrelated chemicals, improve or resolve when the incitants are removed, and involve multiple organ systems.[1]

That definition gives us a fence around the discussion.

When we say MCS in this article, we are talking about that pattern.

And when we look specifically at that pattern, our conclusion is this:

In people meeting established MCS criteria, the weight of the evidence supports an environmentally initiated and environmentally triggered physiological disorder. Psychological causation does not explain the MCS pattern, and changing thought patterns has not been shown to reverse the disorder or reliably restore chemical tolerance.

That is a strong statement. It deserves strong evidence.

The mistake: treating three different questions as though they were one

Much of the argument over MCS becomes clearer when we separate three questions that have repeatedly been blended together.

What starts the illness?

What happens after the illness exists—including conditioning, stress, expectation, sensitization and amplification?

What has actually been shown to reverse it?

Those are not the same question.

A psychological process could influence symptoms without having caused the disease. A nervous-system mechanism could be involved without being consciously controlled. A therapy could improve fear or coping without restoring chemical tolerance. And an environmental exposure could initiate biological changes without every later low-level reaction representing a new episode of classical toxic poisoning.

Once those distinctions are made, a great deal of the apparent contradiction begins to disappear.

Why we take environmental initiation seriously

MCS does not exist only as anonymous anecdotes on the Internet. There are occupational cohorts in which people developed the pattern following workplace exposures.

In one occupational-health study, 35 people with work-related MCS were examined for onset and progression. Solvents, poor indoor-air quality and remodeling were among the reported initiating contexts.[2]

Another study examined 112 people who reported developing chemical sensitivity after either cholinesterase-inhibiting pesticide exposure or building remodeling. Despite very different initiating exposures, the two groups later reported similar patterns of chemical and food intolerance. The study did not prove a single biological mechanism, but it documented the repeated initiation-and-triggering pattern that helped shape later research.[3]

More recent population research has also found that people with chemical intolerance report a range of possible initiating events, including mold, pesticides, medical or surgical events, new construction or remodeling, and combustion products. Importantly, these are retrospective reports rather than prospective proof of causation, and many people do not identify an initiating event at all.[4]

That distinction matters to us.

We are not claiming that every person with MCS can point to a single chemical accident. Some can. Some describe repeated lower-level exposures. Some become sick and do not understand what happened until much later. Some never identify an initiating event.

That is why the Canary Registry will ask a question that has rarely been studied properly:

Which came first—the illness, or the belief about what was causing it?

If people were already sick before they knew an exposure had occurred, that chronology matters. It doesn't by itself prove a mechanism. But it directly tests one of the central assumptions behind a purely expectation-driven explanation.

Gulf War illness gives us another reason to look seriously at susceptibility and exposure

The Gulf War is important because large groups of people shared a defined deployment environment and later developed chronic multisystem illness.

In a British cohort comparing Gulf War veterans, Bosnia veterans and nondeployed Gulf-era personnel, MCS was reported more often in the Gulf group. Within Gulf veterans, MCS was associated with self-reported pesticide exposure, although the investigators appropriately warned about recall bias.[5]

This does not mean Gulf War illness and MCS are identical.

It means something more useful: it gives us a real-world population in which environmental exposure, individual susceptibility, neurological symptoms and chronic multisystem illness intersect.

Why can two people share an environment while only one becomes chronically sensitive? Genetics? Previous exposures? Immune state? Autonomic regulation? Sensory-neuron biology? Epigenetic differences? Something else entirely?

That question—why this person and not the person beside them?—may ultimately tell us more about MCS than simply cataloging triggers.

Then there is the physiology

If MCS were only a belief about chemicals, we would expect the most interesting evidence to remain primarily psychological. It hasn't.

One line of research involves capsaicin, the compound that gives chili peppers their heat and activates the TRPV1 sensory pathway. In a double-blind randomized capsaicin challenge, people meeting MCS criteria coughed more and experienced more symptoms than healthy controls. The investigators concluded that airway sensory reactivity was increased and that neurogenic mechanisms could be important.[6]

That does not prove that TRPV1 causes MCS. But it gives us an objectively measurable difference in sensory responsiveness.

Another line comes from brain imaging. A review of 23 studies found consistent evidence of altered neurological processing of sensory information in chemically intolerant subjects, particularly involving limbic and related cortical regions.[7]

That distinction is crucial. A different brain scan does not tell us, by itself, why the brain became different. Brains change after learning, injury, chronic pain, trauma, repeated sensory input and disease.

So we don't use brain scans as a rhetorical trick—“See, it's physical, argument over.” We use them for what they actually show: something about neurological processing is different.

Immune research adds another clue. A Danish case-control study compared 150 people with MCS with 148 age- and sex-matched healthy controls and found a distinct cytokine profile, including elevations in several pro-inflammatory cytokines. The authors described the pattern as suggestive of low-grade systemic inflammation and altered immune signaling.[8]

Again: clue, not final mechanism.

Recent reviews have pulled many of these findings together. TRPV1 and TRPA1 sensory receptors deserve serious attention alongside genetic influences, gene-environment interactions, oxidative stress, systemic inflammation, cellular dysfunction and psychosocial influences.[9]

This is why our working hypothesis is broader.

We call it environmental hyperresponsiveness.

Not as a new diagnosis. Not as something we claim has already been proven. As a research framework.

The idea is that susceptible people may enter an acquired high-gain state in which sensory nerves, central sensory processing, autonomic regulation, immune or inflammatory signaling, mast-cell pathways, oxidative and metabolic regulation—or some combination of them—respond abnormally to environmental inputs that were previously tolerated.

The important question is not which fashionable mechanism wins.

The important question is:

What changed?

Why the strongest opposing evidence still does not establish psychological causation

If we are going to say we followed the evidence, we cannot bury the studies that seem to contradict us.

The 2006 Das-Munshi provocation review is the paper most often used to call MCS psychological, and it cannot establish that conclusion because it studied reactions after chemical sensitivity already existed rather than the onset of the illness. It examined 37 provocation studies involving hundreds of chemically sensitive participants and controls.[10]

Their findings deserve to be taken seriously.

Blinding was inadequate in most studies. When participants could probably tell that they were receiving the active chemical, positive responses were common. In several better-masked studies, responses did not track the active exposure consistently. The reviewers concluded that people with MCS do react during chemical challenges, but that reactions often depend on their ability to distinguish active from sham exposure, suggesting an important role for expectations and prior beliefs.[10]

That is real evidence. We do not explain it away.

It tells us something important:

Expectation, perception and learned association can influence an MCS response.

That should be part of any serious model of the condition.

But there is a more basic problem with using the provocation studies to explain the entire disorder. They primarily address what happens after somebody already has MCS. They do not show what happened when that person's illness began.

A person can acquire a conditioned response after becoming sick. Expectation can amplify an already sensitized system. Fear can increase autonomic activation. The brain can learn that a certain odor predicts illness.

All of those things can be true without belief having created the original condition.

That distinction—initiation versus amplification—is one of the most important distinctions in the entire MCS debate.

The predictive brain is real. That doesn't make every illness a prediction error.

Modern neuroscience has taught us that the brain is not simply a camera receiving information from the world. It predicts. It interprets. It learns. It adjusts sensory gain. It can associate sights, smells, places and sensations with danger.

That is why predictive coding, neural circuits, conditioning, “neurotags,” somatic tracking and neuroplasticity deserve a place in the MCS conversation.

But we need to be precise about where they belong.

Pain Reprocessing Therapy and related approaches have produced important randomized evidence in selected chronic-pain populations.[11] That is meaningful evidence about chronic pain. It is not an MCS trial.

We cannot take a mechanism that appears important in one illness, notice that MCS also involves the nervous system, and then declare that the same mechanism must be the root cause of MCS.

The same scientific standard has to apply in both directions.

Neuroplasticity is real. Prediction is real. Conditioning is real.

And none of those facts establishes that consensus-defined MCS originates in maladaptive thought or can generally be reversed by changing thought.

The brain is part of the body. Neurological does not mean psychological.

The treatment evidence is where the claim should have succeeded—if it were true

There is an especially useful way to test the stronger brain-retraining theory.

If MCS is fundamentally maintained by maladaptive thoughts, predictions and learned danger circuits, then changing those processes should not merely make people less frightened. It should change the MCS itself.

That question has been studied.

In the strongest MCS-specific randomized trial, 69 participants received mindfulness-based cognitive therapy or treatment as usual and were followed for a year. The intervention produced positive changes in illness perceptions, but it did not improve the primary MCS outcome. The researchers concluded that MBCT changed emotional and cognitive representations of illness without changing overall MCS illness status.[12]

An earlier randomized pilot involving 37 people likewise found no significant between-group treatment effect, although participants who completed the program reported improvements in areas such as coping and sleep.[13]

That is why wording matters so much here.

If an intervention improves fear, we should say fear improved. If it improves sleep, say sleep improved. If it improves coping, say coping improved. If it improves function, say function improved.

But none of those outcomes should quietly be translated into: “The MCS was reversed.”

Some people do report substantial improvement after brain-retraining programs. Their experiences deserve respect and study.

But a testimonial cannot tell us by itself what caused that person's illness, whether the person met established MCS criteria, which part of a multicomponent program produced the improvement, what else changed in the person's environment at the same time, or whether chemical tolerance actually returned.

That is not a reason to dismiss those stories. It is a reason to study them properly.

Our Canary Registry will do exactly that.

The mind matters. It just isn't a master switch.

None of this requires us to take the opposite extreme and pretend that thoughts, fear, stress and expectation do nothing.

They do.

Anyone who has experienced pain knows that attention can change it. Anyone who has been frightened knows that thought can change heart rate, breathing, sweating, muscle tension and digestion. Expectation can change symptoms. Stress can worsen illness. Safety and calm can improve the way a person experiences and carries illness.

We should use every legitimate tool that helps.

But there is a difference between saying the mind influences the body and saying the mind created the disease and can therefore think it away.

Think of an injured arm. Fear, confidence, rehabilitation and expectation can affect pain, movement, avoidance and recovery. Those things matter enormously. But the fact that the brain influences recovery does not mean the injury was imaginary. And it does not give thought unlimited control over biology.

That is how we approach nervous-system work in MCS.

Mindset can be a modifier without being the master switch.

What about avoidance?

Read the page: Does avoiding chemicals help MCS? · Can repeated exposure make MCS worse?

Avoidance has also been treated ideologically.

Some patients are told that reducing exposure merely reinforces fear and therefore makes them more sensitive.

Again, the evidence is not that simple.

In a survey of 917 people with self-reported MCS who had tried 101 different treatments, chemical avoidance and creating a chemical-free living space were the two highest-rated approaches. That is self-reported treatment experience, not a randomized trial, so it should not be mistaken for proof of cure.[14]

There is also intervention evidence in which measured reductions in volatile organic compounds in people's homes generally tracked with symptom improvement.[15]

This does not establish one universal mechanism. It does establish that the environment cannot simply be written out of the story.

Reducing an exposure that repeatedly makes a person ill is not automatically “fear behavior.” It may be prudent disease management.

At the same time, we do not claim that more avoidance is always better, that every exposure causes permanent harm, or that carefully controlled re-exposure could never play a role in recovery for some people.

Those are research questions.

The goal is not maximum avoidance forever.

The goal is health, function and restored tolerance.

Where the evidence leads us

After weighing the evidence, we do not split the difference simply because competing explanations exist.

We land where the weight of the evidence points.

Multiple Chemical Sensitivity is a real physiological disorder characterized by abnormal responses to environmental exposures.

In people meeting the established consensus criteria, the evidence supports an environmentally initiated and environmentally triggered physiological disorder.

The nervous system is deeply involved. So are sensory pathways. Autonomic abnormalities deserve investigation. Immune and inflammatory signaling deserve investigation. Mast-cell biology deserves investigation. Genetics, epigenetics and susceptibility deserve investigation. TRPV1 and TRPA1 deserve investigation. Predictive processing, conditioning and neuroplasticity deserve investigation too.

Those are not competing religions. They are possible parts of one biological system.

What we reject is the unsupported leap from “The brain is involved” to “therefore thought caused it.”

And we reject the equal and opposite leap from “chemicals trigger symptoms” to “therefore every low-level reaction is classical toxic poisoning.”

A real environmental trigger does not require every later reaction to be a fresh episode of dose-dependent toxic injury. A sensitized or dysregulated biological system can itself respond disproportionately to an exposure.

That is precisely what needs to be understood.

Real, not imagined. Managed, not cured.

This is where we need to be equally careful about hope.

Some people improve substantially. Some regain function. Some regain tolerance. Some describe long periods of remission. Others improve and later relapse. Others remain severely sensitive for many years.

We should not turn the best outcome into a promise to everybody. And we should not turn the worst outcome into everybody's destiny.

That is why our public line is:

Real, not imagined. Managed, not cured.

“Managed, not cured” means there is presently no treatment shown to reliably eliminate MCS and permanently restore normal chemical tolerance. It does not mean that substantial improvement, remission, regained function or increased tolerance cannot occur.

In fact, one of the most important research questions before us is why outcomes differ so dramatically.

Perhaps that question will eventually matter more to patients than proving how the illness began.

What distinguishes someone who regains substantial tolerance from someone who remains highly sensitive? Was the initiating exposure different? Was the duration of exposure different? Is there a different genetic susceptibility? A different autonomic phenotype? Mast-cell involvement? Small-fiber involvement? A different sensory-response pattern? Did prolonged exposure reduction permit biological recovery? Did conditioning become a larger component for one subgroup? Did an infection, head injury, trauma or other physiological event change the course?

We don't need to guess.

We can measure.

From argument to measurement

That is the purpose of I'm a Canary.

MCSDisability has a position. The Canary Registry cannot.

MCSDisability looks at the existing evidence and says: Here is where it leads.

I'm a Canary asks: Can we test it?

We are particularly interested in three questions.

The first is Illness Before Awareness. Did people become physically ill before they knew an environmental exposure might be involved?

The second is the overlap question. Why do MCS, EHS, MCAS, POTS/dysautonomia, ME/CFS, migraine, fibromyalgia, Gulf War illness and other conditions overlap in some people? Are these simply different diseases that commonly occur together, or do some of them reveal a shared vulnerability in sensory, autonomic, immune or environmental-response systems?

The third is the recovery phenotype. Why do some people regain substantial tolerance while others relapse or remain chronically sensitive?

Those questions need something the MCS debate has too often lacked: chronology.

What was the person like before illness? What happened before onset? When did the illness begin? When did the person first suspect an environmental cause? What happened when exposure stopped? What happened when exposure returned? What treatments were tried? Which specific outcomes changed? What remained? What returned? And which findings can be independently documented?

The registry must be capable of proving our position wrong.

Otherwise it is advocacy disguised as science.

The question has changed

For too long, MCS has been trapped inside a question that is too small:

Are these people really sick, or is it in their heads?

We think the evidence has moved beyond that question.

People with MCS are sick. Their nervous systems are involved because nervous systems are biological. Environmental exposures are central to the pattern. Expectation and conditioning can modify responses without explaining the origin of the disorder. Brain-based methods can improve specific outcomes without having been shown to reverse MCS. Exposure reduction can be legitimate management without proving that every reaction is conventional poisoning. And promising biological mechanisms can be pursued without prematurely declaring one of them the answer.

The scientific questions now are harder—and much more interesting:

What changed in the body?

What initiated that change?

Why are some people susceptible while others sharing the same environment are not?

Which sensory, neurological, autonomic, immune, inflammatory or metabolic systems are altered?

Why do previously tolerated exposures trigger illness afterward?

Why do some people eventually regain tolerance?

And finally:

How do we help the body restore it?

That is where we believe the MCS conversation belongs now.

Not in dismissal. Not in dogma. Not in another war between “toxic” and “psychological.”

In evidence. In measurement. And in finding out what changed.

References

References

1Multiple chemical sensitivity: a 1999 consensus. Archives of Environmental Health. 1999;54(3):147-149. PMID: 10444033. DOI: 10.1080/00039899909602251.
2Lax MB, Henneberger PK. Patients with multiple chemical sensitivities in an occupational health clinic: presentation and follow-up. Archives of Environmental Health. 1995. PMID: 8572720.
3Miller CS, Mitzel HC. Chemical sensitivity attributed to pesticide exposure versus remodeling. Archives of Environmental Health. 1995. PMID: 7786048.
4Palmer RF, et al. Assessing chemical intolerance in U.S. adults and self-reported initiating events. Environmental Sciences Europe. 2023.
5Reid S, et al. Multiple chemical sensitivity and chronic fatigue syndrome in British Gulf War veterans. American Journal of Epidemiology. 2001. PMID: 11257069.
6Ternesten-Hasséus E, Bende M, Millqvist E. Increased capsaicin cough sensitivity in patients with multiple chemical sensitivity. Journal of Occupational and Environmental Medicine. 2002;44(11):1012-1017. PMID: 12448352.
7Chemical intolerance: involvement of brain function and networks after exposure to extrinsic stimuli perceived as hazardous. Review of 23 studies. 2019. PMID: 31640568.
8Dantoft TM, et al. An elevated pro-inflammatory cytokine profile in multiple chemical sensitivity. Psychoneuroendocrinology. 2014;40:140-150. PMID: 24485486.
9Molot J, Sears M, Anisman H. Multiple chemical sensitivity: It's time to catch up to the science. Neuroscience & Biobehavioral Reviews. 2023;151:105227. PMID: 37172924.
10Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. Journal of Allergy and Clinical Immunology. 2006;118(6):1257-1264. PMID: 17137865.
11Ashar YK, et al. Effect of Pain Reprocessing Therapy vs placebo and usual care for patients with chronic back pain: a randomized clinical trial. JAMA Psychiatry. 2022;79(1):13-23. PMID: 34586357.
12Hauge CR, et al. Mindfulness-based cognitive therapy for multiple chemical sensitivity: randomized controlled trial with 1-year follow-up. Journal of Psychosomatic Research. 2015;79(6):628-634. PMID: 26311155.
13Skovbjerg S, et al. Mindfulness-based cognitive therapy for multiple chemical sensitivity: a randomized pilot study. Journal of Psychosomatic Research. 2012. PMID: 22530938.
14Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environmental Health Perspectives. 2003. PMID: 12948890.
15Indoor VOC-reduction intervention in people with chemical intolerance. 2022. PMID: 35019834.
← Back to MCSDisability.com
↑